HIV Vaccine Breakthroughs: Who Pays?

Anthony Canamucio In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals. --Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" be

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals.

--Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India

On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" becomes a reality. This is precisely the issue facing the sponsors of HIV vaccine clinical trials in developing countries concerning the treatment of vaccine breakthroughs--individuals who become infected after immunization because the vaccine failed to protect them.

Prior to the advent of potent antiretroviral therapy (ART), HIV vaccine trials offered an opportunity to study both the efficacy of an HIV vaccine and the potential to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Arthur Ammann

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo